Company Filing History:
1 out of 9 
1 out of 10 Years Active: 2013
Title: The Innovations of Petrus Johannes Loius Spee
Introduction
Petrus Johannes Loius Spee is a notable inventor based in Allerod, Denmark. He has made significant contributions to the field of immunology, particularly through his innovative work on antibodies. His research focuses on enhancing the immune response in subjects, which has important implications for therapeutic applications.
Latest Patents
Petrus holds a patent for "Nucleic acids encoding human anti-kir antibodies." This patent describes compositions and methods for regulating an immune response in a subject. Specifically, it details human antibodies that regulate the activity of natural killer (NK) cells, allowing for the potentiation of NK cell cytotoxicity in mammalian subjects. The patent also covers antibodies with antigen-binding properties similar to those of human monoclonal antibodies 1-7F9 or 1-4F1. Additionally, it describes fragments and derivatives of these antibodies, as well as pharmaceutical compositions that include them, particularly for therapeutic use to increase NK cell activity or cytotoxicity in subjects. Petrus has 1 patent to his name.
Career Highlights
Throughout his career, Petrus has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Novo Nordisk A/S and Innate Pharma S.A.S. His work in these organizations has allowed him to contribute to advancements in therapeutic solutions and immunological research.
Collaborations
Petrus has collaborated with esteemed colleagues in the field, including Alessandro Moretta and Mariella Della Chiesa. These collaborations have further enriched his research and innovation efforts.
Conclusion
Petrus Johannes Loius Spee is a distinguished inventor whose work on antibodies has the potential to significantly impact therapeutic strategies in immunology. His innovative contributions continue to pave the way for advancements in enhancing immune responses.